Fund overlap
Nippon India Pharma Fund vs DSP Healthcare Fund
Fund A
Nippon India Pharma Fund
Nippon India Pharma Fund - Direct Plan - IDCW Option
Open Ended Schemes(Equity Schemes - Sectoral Fund) · Nippon India Mutual Fund
Fund B
DSP Healthcare Fund
DSP Healthcare Fund - Direct Plan - Growth
Open Ended Schemes(Equity Schemes - Sectoral Fund) · DSP Mutual Fund
Overlap
26.2%
- Shared holdings
- 15
- Holdings in A
- 38
- Holdings in B
- 33
Overlap measures how closely the two portfolios match, holding by holding and weight by weight, using each fund's latest disclosed holdings. 100% would mean the same holdings at the same weights.
Shared holdings
The 10 largest of 15 shared holdings, ordered by the smaller of the two weights.
| Holding | Nippon India Pharma Fund | DSP Healthcare Fund |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.71% | 7.44% |
| Cipla Limited | 6.01% | 7.18% |
| Apollo Hospitals Enterprise Limited | 4.89% | 6.07% |
| Divi's Laboratories Limited | 7.10% | 4.17% |
| Sai Life Sciences Limited | 3.92% | 6.52% |
| IPCA Laboratories Limited | 2.87% | 8.13% |
| Gland Pharma Limited | 2.53% | 6.15% |
| Vijaya Diagnostic Centre Limited | 2.62% | 2.36% |
| Thyrocare Technologies Limited | 2.24% | 1.91% |
| Alkem Laboratories Limited | 1.82% | 4.75% |
Data as of 30 Sept 2026
Method: weighted Jaccard
Weighted Jaccard adds up the smaller weight of every holding across both funds and divides by the sum of the larger weights.